MetaCap

Bicara Therapeutics (BCAX) vs OPKO Health (OPK)

Head-to-head comparison of performance, valuation, growth, profitability and dividends. Prices delayed 15 minutes; data as of Oct 7, 2026.

Summary

Bicara Therapeutics (BCAX) has outperformed OPKO Health (OPK) over the past year, losing 9.6% versus a loss of 9.7%. Bicara Therapeutics is the larger company by market cap ($1.09 billion vs $1.04 billion), about 1.0 times the size.

Summary generated from market data by MetaCap's automated system. Methodology

Relative performance

BCAX-8.93%OPK-12.03%
+74%+19%-35%
Oct 6, 20251 yearOct 7, 2026
BCAX-29.86%OPK-11.46%
+28%-19%-67%
Sep 9, 20245 yearsOct 5, 2026

Percent change in share price from the first common trading day shown; excludes dividends.

Head-to-head

BCAX versus OPK key metrics
MetricBCAXOPK
Share price$16.42$1.39
Market cap$1.09B$1.04B
1-day change-0.85%-4.79%
YTD return-2.44%+10.32%
1-year return-9.63%-9.74%
5-year return—-62.63%
EPS (TTM)$-3.08$-0.09
Dividend yield0.00%0.00%
Annual dividend$0.00$0.00
52-week high$30.99$1.75
52-week low$13.70$0.98
Distance from 52-week high-47.02%-20.57%
Average volume609.70K3.35M
Shares outstanding66.17M746.33M
SectorHealth CareHealth Care
IndustryBiotechnology: Pharmaceutical PreparationsBiotechnology: Pharmaceutical Preparations

Highlighted cells mark the higher value for growth, returns, margins and yield, and the lower value for P/E ratios. Highlighting is a mechanical comparison, not a recommendation.

BCAX vs OPK FAQ

Which is bigger, Bicara Therapeutics or OPKO Health?

Bicara Therapeutics (BCAX) is larger, with a market capitalization of $1.09B compared with $1.04B for OPKO Health (OPK).

Which stock has performed better over the past year, BCAX or OPK?

BCAX returned -9.63% over the past 12 months, compared with -9.74% for OPK (price return, excluding dividends). Past performance does not predict future results.

Are Bicara Therapeutics and OPKO Health in the same industry?

Yes. Both are classified in the Biotechnology: Pharmaceutical Preparations industry within the Health Care sector.

More comparisons